CN110882412A - 一种抗菌消炎的医用凝胶及其制备方法 - Google Patents
一种抗菌消炎的医用凝胶及其制备方法 Download PDFInfo
- Publication number
- CN110882412A CN110882412A CN201911255519.3A CN201911255519A CN110882412A CN 110882412 A CN110882412 A CN 110882412A CN 201911255519 A CN201911255519 A CN 201911255519A CN 110882412 A CN110882412 A CN 110882412A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- prepared
- taking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 28
- 230000003110 anti-inflammatory effect Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 238000001879 gelation Methods 0.000 title description 2
- 239000000499 gel Substances 0.000 claims abstract description 82
- 239000003814 drug Substances 0.000 claims abstract description 58
- 239000000654 additive Substances 0.000 claims abstract description 47
- 230000000996 additive effect Effects 0.000 claims abstract description 47
- 239000004005 microsphere Substances 0.000 claims abstract description 47
- 108010010803 Gelatin Proteins 0.000 claims abstract description 32
- 239000008273 gelatin Substances 0.000 claims abstract description 32
- 229920000159 gelatin Polymers 0.000 claims abstract description 32
- 235000019322 gelatine Nutrition 0.000 claims abstract description 32
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 32
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229920001661 Chitosan Polymers 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 23
- 239000000661 sodium alginate Substances 0.000 claims abstract description 23
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 23
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 23
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims abstract description 22
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 21
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 19
- 229960001631 carbomer Drugs 0.000 claims abstract description 19
- 238000003809 water extraction Methods 0.000 claims abstract description 11
- 206010061218 Inflammation Diseases 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims description 61
- 239000000463 material Substances 0.000 claims description 58
- 239000006228 supernatant Substances 0.000 claims description 35
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000003431 cross linking reagent Substances 0.000 claims description 23
- 239000003999 initiator Substances 0.000 claims description 22
- ZXLYUNPVVODNRE-UHFFFAOYSA-N 6-ethenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=C)=N1 ZXLYUNPVVODNRE-UHFFFAOYSA-N 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 21
- 239000003995 emulsifying agent Substances 0.000 claims description 20
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 19
- 239000001263 FEMA 3042 Substances 0.000 claims description 19
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 19
- 238000001035 drying Methods 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 19
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 19
- 229940033123 tannic acid Drugs 0.000 claims description 19
- 235000015523 tannic acid Nutrition 0.000 claims description 19
- 229920002258 tannic acid Polymers 0.000 claims description 19
- 239000002994 raw material Substances 0.000 claims description 18
- 241000245665 Taraxacum Species 0.000 claims description 17
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 17
- 210000004623 platelet-rich plasma Anatomy 0.000 claims description 17
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 16
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 16
- 229940057995 liquid paraffin Drugs 0.000 claims description 15
- 241000037740 Coptis chinensis Species 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 239000005457 ice water Substances 0.000 claims description 14
- 235000019830 sodium polyphosphate Nutrition 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 12
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical group [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 9
- 229940116229 borneol Drugs 0.000 claims description 9
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 9
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 9
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 108090000190 Thrombin Proteins 0.000 claims description 7
- 230000003213 activating effect Effects 0.000 claims description 7
- 239000012190 activator Substances 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 230000001804 emulsifying effect Effects 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 229960004072 thrombin Drugs 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 238000001179 sorption measurement Methods 0.000 claims description 6
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 claims description 5
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 5
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 5
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical group C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 230000003260 anti-sepsis Effects 0.000 claims 3
- 230000003115 biocidal effect Effects 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 10
- 239000001257 hydrogen Substances 0.000 abstract description 10
- 239000003102 growth factor Substances 0.000 abstract description 8
- 230000029663 wound healing Effects 0.000 abstract description 7
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000000857 drug effect Effects 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 230000000694 effects Effects 0.000 description 9
- 239000000017 hydrogel Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 240000003152 Rhus chinensis Species 0.000 description 4
- 235000014220 Rhus chinensis Nutrition 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 241000218202 Coptis Species 0.000 description 3
- 235000002991 Coptis groenlandica Nutrition 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 239000004964 aerogel Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 241000212948 Cnidium Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000010382 chemical cross-linking Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Abstract
Description
Claims (9)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911255519.3A CN110882412B (zh) | 2019-12-10 | 2019-12-10 | 一种抗菌消炎的医用凝胶及其制备方法 |
CN202011117926.0A CN112294877B (zh) | 2019-12-10 | 2019-12-10 | 抗菌消炎的医用凝胶 |
CN202011119528.2A CN112336913B (zh) | 2019-12-10 | 2019-12-10 | 一种抗菌消炎的医用凝胶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911255519.3A CN110882412B (zh) | 2019-12-10 | 2019-12-10 | 一种抗菌消炎的医用凝胶及其制备方法 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011119528.2A Division CN112336913B (zh) | 2019-12-10 | 2019-12-10 | 一种抗菌消炎的医用凝胶 |
CN202011117926.0A Division CN112294877B (zh) | 2019-12-10 | 2019-12-10 | 抗菌消炎的医用凝胶 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110882412A true CN110882412A (zh) | 2020-03-17 |
CN110882412B CN110882412B (zh) | 2020-11-20 |
Family
ID=69751218
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011117926.0A Active CN112294877B (zh) | 2019-12-10 | 2019-12-10 | 抗菌消炎的医用凝胶 |
CN201911255519.3A Active CN110882412B (zh) | 2019-12-10 | 2019-12-10 | 一种抗菌消炎的医用凝胶及其制备方法 |
CN202011119528.2A Active CN112336913B (zh) | 2019-12-10 | 2019-12-10 | 一种抗菌消炎的医用凝胶 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011117926.0A Active CN112294877B (zh) | 2019-12-10 | 2019-12-10 | 抗菌消炎的医用凝胶 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011119528.2A Active CN112336913B (zh) | 2019-12-10 | 2019-12-10 | 一种抗菌消炎的医用凝胶 |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN112294877B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111643724A (zh) * | 2020-07-01 | 2020-09-11 | 南京大学 | 一种载有噬菌体和酸性成纤维细胞生长因子的水凝胶伤口敷料的制备方法及其应用 |
CN116392629A (zh) * | 2023-04-13 | 2023-07-07 | 吉林大学 | 一种多功能水凝胶敷料及其制备方法和应用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113855852B (zh) * | 2021-09-28 | 2022-06-28 | 蓝科医美科学技术(吉林)有限公司 | 一种含有人参提取物的修复敷料及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105030815A (zh) * | 2015-08-10 | 2015-11-11 | 贵州扬生医用器材有限公司 | 一种手术冲洗液及其制法 |
CN106924196A (zh) * | 2017-03-06 | 2017-07-07 | 广州军区广州总医院 | 一种负载生长因子的明胶缓释微球及其制备方法 |
CN108671263A (zh) * | 2018-06-04 | 2018-10-19 | 界首市龙鑫生物科技有限公司 | 一种医用抗菌水凝胶敷料制备方法 |
CN108939142A (zh) * | 2018-07-05 | 2018-12-07 | 安徽玉然经编科技有限公司 | 一种含复合抗菌微球的敷料 |
CN110330669A (zh) * | 2019-06-21 | 2019-10-15 | 湖北工业大学 | 聚(丙烯酰胺-vdt)/ta高强度水凝胶的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104873467B (zh) * | 2014-02-28 | 2017-10-10 | 江南大学 | 一种生物降解型互穿网络聚合物微球的制备方法 |
-
2019
- 2019-12-10 CN CN202011117926.0A patent/CN112294877B/zh active Active
- 2019-12-10 CN CN201911255519.3A patent/CN110882412B/zh active Active
- 2019-12-10 CN CN202011119528.2A patent/CN112336913B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105030815A (zh) * | 2015-08-10 | 2015-11-11 | 贵州扬生医用器材有限公司 | 一种手术冲洗液及其制法 |
CN106924196A (zh) * | 2017-03-06 | 2017-07-07 | 广州军区广州总医院 | 一种负载生长因子的明胶缓释微球及其制备方法 |
CN108671263A (zh) * | 2018-06-04 | 2018-10-19 | 界首市龙鑫生物科技有限公司 | 一种医用抗菌水凝胶敷料制备方法 |
CN108939142A (zh) * | 2018-07-05 | 2018-12-07 | 安徽玉然经编科技有限公司 | 一种含复合抗菌微球的敷料 |
CN110330669A (zh) * | 2019-06-21 | 2019-10-15 | 湖北工业大学 | 聚(丙烯酰胺-vdt)/ta高强度水凝胶的制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111643724A (zh) * | 2020-07-01 | 2020-09-11 | 南京大学 | 一种载有噬菌体和酸性成纤维细胞生长因子的水凝胶伤口敷料的制备方法及其应用 |
CN111643724B (zh) * | 2020-07-01 | 2022-01-28 | 南京大学 | 一种载有噬菌体和酸性成纤维细胞生长因子的水凝胶伤口敷料的制备方法及其应用 |
CN116392629A (zh) * | 2023-04-13 | 2023-07-07 | 吉林大学 | 一种多功能水凝胶敷料及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN112336913B (zh) | 2022-04-22 |
CN112294877A (zh) | 2021-02-02 |
CN112336913A (zh) | 2021-02-09 |
CN112294877B (zh) | 2022-05-27 |
CN110882412B (zh) | 2020-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110882412B (zh) | 一种抗菌消炎的医用凝胶及其制备方法 | |
CN110354295B (zh) | 一种光热转换材料及其制备方法 | |
CN103463668B (zh) | 一种丝素-海藻酸钙生物创面多孔敷料的制备方法 | |
CN103341203B (zh) | 一种药用敷料、药用敷料制作方法及敷料贴的制作方法 | |
CN112370567A (zh) | 一种具有抗菌消炎功能的水凝胶活性敷料 | |
CN110522945B (zh) | 一种医用生物凝胶止血敷料及其制备方法 | |
CN105816911A (zh) | 一种含生长因子的修复凝胶及其制备方法 | |
CN113018502B (zh) | 一种医用多功能止血敷料及其制备方法 | |
CN103755965A (zh) | 一种ε-聚赖氨酸水凝胶及其制备方法和应用 | |
WO2012036589A1 (ru) | Гидрогелевая композиция для лечения ожогов | |
CN106421868A (zh) | 一种壳聚糖季铵盐猪脱细胞真皮基质敷料及其制备方法 | |
CN105381497B (zh) | 一种抗菌止血敷料的制备方法 | |
CN104208741A (zh) | 一种壳聚糖基创口贴 | |
CN108686103B (zh) | 一种止血中药组合物以及多功能紧急止血复合材料 | |
CN108578540A (zh) | 一种抑制疤痕和促进伤口愈合的生物配方及其制备方法 | |
CN111317855B (zh) | 促进糖尿病溃疡创面愈合的三维复合海绵状结构体及方法 | |
CA2749863A1 (en) | Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues | |
CN113209354A (zh) | 一种抗菌敷料的制备方法 | |
CN102614544B (zh) | 纳米银抗菌敷料的制备方法及应用 | |
CN104324413A (zh) | 一种水凝胶敷料的制备方法 | |
CN106937942A (zh) | 一种医用皮肤伤口镇痛凝胶及其制备方法 | |
CN102988407A (zh) | 淀粉-透明质酸止血剂及其制备方法 | |
CN106729925A (zh) | 一种用于伤口修复的凝胶喷雾剂的制备方法和凝胶喷雾剂 | |
Khalid et al. | Polysaccharide composites as a wound-healing sponge | |
CN103061109A (zh) | 非水溶性壳聚糖纤维改性成水溶性壳聚糖纤维的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201015 Address after: Liushi Town, Yueqing city of Zhejiang Province, Wenzhou City West 325600 Ren Dang village Applicant after: Yueqing chenzhuo Electric Co.,Ltd. Address before: 215000 room 701, building 18, ink garden, Zhongyuan Road, Suzhou Industrial Park, Jiangsu Province Applicant before: Yang Xin |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201106 Address after: No.171 Xiajiashan village, Lucheng District, Wenzhou City, Zhejiang Province 325600 Applicant after: Li Jianxun Address before: Liushi Town, Yueqing city of Zhejiang Province, Wenzhou City West 325600 Ren Dang village Applicant before: Yueqing chenzhuo Electric Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220628 Address after: 518000 1712y13, Huarong Building, No. 178, mintian Road, Fu'an community, Futian street, Futian District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Rongxi Biotechnology Co.,Ltd. Address before: No. 171, Xiajiashan village, Lucheng District, Wenzhou City, Zhejiang Province 325600 Patentee before: Li Jianxun |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230509 Address after: No. 2911, Office Building 2, Zone C, Kaifu Wanda Plaza, No. 589, Zhongshan Road, Tongtai Street, Kaifu District, Changsha City, Hunan Province, 410000 Patentee after: Changsha Rongxi Biotechnology Co.,Ltd. Address before: 518000 1712y13, Huarong Building, No. 178, mintian Road, Fu'an community, Futian street, Futian District, Shenzhen City, Guangdong Province Patentee before: Shenzhen Rongxi Biotechnology Co.,Ltd. |